Non selective non-steroidal anti-inflammatory drugs (NSAIDs): new assessment in process

The Committee for Medicinal Products for Human Use of the European Medicines Agency has begun the analyse of the results of the independent epidemiological study funded by the European Commission to better assess the risk of gastro-intestinal and cardiovascular toxicity of non-selective NSAIDs. Following this review recommendations will be issued if needed.

See EMA website

Contact: vig@fagg-afmps.be

 

 

 

 

 

 

 

 

 

Last updated on
30/11/2011